Support of Medication Assisted Treatment
COMPA: The Coalition of Medication Assisted Treatment Providers and Advocates endorses and supports evidence-based comprehensive treatment services for addiction, which includes the immediate access to the appropriate use of each of the three FDA approved medications for the treatment of Opiate Use Disorder. We are pleased to share the Opportunity for Expansion of OUD Medication Assisted Treatment within OTPs by Incorporating Extended Release Naltrexone by Sonia J. Lopez and Soteri Polydorou, MD regarding the integration of Vivitrol into the OTP continuum.
- Assessing the Evidence: Medication Assisted Treatment with Methadone
- Assessing the Evidence: Medication Assisted Treatment with Buprenorphine
- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
- OASAS Addiction Medications
- Report on Model Policy on DATA 2000
- Methadone 101 Video
- Addictive cravings still detectable after death
- NIH Opioid Consensus Statement
- PCSS-MAT
- PCSS-O
- PCSS CoOp Model
Corporate Members
Recent News and Notices
We've moved. New address:
121 West 36th Street #201
New York, NY 10018.
- Apply to Increase Capacity in OTP
- Value Based Bootcamps Payment Overview
- Value Based Payment Roadmap (2016)
- Billing for Buprenorphine in OTPs(note changes effective of July 1, 2015)
- Nurse practitioners (NPs) and physician assistants (PAs) can now train and apply to become DATA-Waiver practitioners. Learn more and sign up for training
- HHS Opioid Epidemic Fact Sheet
- • NYS Integrated Outpatient Services License Presentation
- OASAS Guidance for Services in Community
